Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: Comparison with the Mycobacteria Growth Indicator Tube (MGIT) system

Diagnostic Microbiology and Infectious Disease

Volumn 45, Issue 1, 2003, Pages 53-61

  Bardarov Jr , Svetoslav ^a   Dou, Horng ^a   Eisenach, Katherine ^b   Banaiee, Niaz ^c   Ya, Su ^a   Chan, John ^a   Jacobs Jr , William R ^a   Riska, Paul F ^d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOANALYSIS; BACTERIAL GROWTH; BACTERIUM DETECTION; COMPARATIVE STUDY; INOCULATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; SPUTUM ANALYSIS;

ANTIBIOTICS, ANTITUBERCULAR; BACTERIOLOGICAL TECHNIQUES; COLONY COUNT, MICROBIAL; CULTURE MEDIA; DRUG RESISTANCE, MULTIPLE; HUMANS; LUCIFERASES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0037311101     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00478-9     Document Type: Article

References (28)

1. Alcaide F., Benitez M.A., Escriba J.M., Martin R. Evaluation of the BACTEC MGIT 960 and the MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA AccuProbe. J Clin Microbiol. 38:2000;398-401.
2. Banaiee N., Bobadilla-Del-Valle M., Bardarov S. Jr, Riska P.F., Small P.M., Ponce-De-Leon A., Jacobs W.R. Jr, Hatfull G.F., Sifuentes-Osornio J. Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico. J Clin Microbiol. 39:2001;3883-3888.
3. Bemer P., Palicova F., Rusch-Gerdes S., Drugeon H.B., Pfyffer G.E. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 40:2002;150-154.
4. Bird B.R., Denniston M.M., Huebner R.E., Good R.C. Changing Practices in Mycobacteriology a Follow-up Survey of State and Territorial Public Health Laboratories. J Clin Microbiol. 34:1996;554-559.
5. Brown K.L., Sarkis G.J., Wadsworth C., Hatfull G.F. Transcriptional silencing by the mycobacteriophage L5 repressor. EMBO J. 16:1997;5914-5921.
6. Carriere C., Riska P. F., Zimhony O., Kriakov J., Bardarov S., Burns J., Chan J., & Jacobs W. R., Jr. (1997). Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 35, 3232-3239.
7. Caviedes L., Lee T.S., Gilman R.H., Sheen P., Spellman E., Lee E.H., Berg D.E., Montenegro-James S. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol. 38:2000;1203-1208.
8. Edlin B.R., Tokars J.I., Grieco M.H., Crawford J.T., Williams J., Sordillo E.M., Ong K.R., Kilburn J.O., Dooley S.W., Castro K.G., et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. [see comments] New Engl J Med. 326:1992;1514-1521.
9. Espinal M.A., Kim S.J., Suarez P.G., Kam K.M., Khomenko A.G., Migliori G.B., Baez J., Kochi A., Dye C., Raviglione M.C. Standard short-course chemotherapy for drug-resistant tuberculosis treatment outcomes in 6 countries. [see comments] JAMA. 283:2000;2537-2545.
10. Espinal M.A., Laszlo A., Simonsen L., Boulahbal F., Kim S.J., Reniero A., Hoffner S., Rieder H.L., Binkin N., Dye C., Williams R., Raviglione M.C. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. New Engl J Med. 344:2001;1294-1303.
11. Hadgu A. Discrepant analysis is an inappropriate and unscientific method. J Clin Microbiol. 38:2000;4301-4302.
12. Heifets L.B., Cangelosi G.A. Drug susceptibility testing of Mycobacterium tuberculosis a neglected problem at the turn of the century. [see comments] Int J Tuberc Lung Dis. 3:1999;564-581.
13. Heifets L.B., Good R.C. Current Laboratory Methods for the Diagnosis of Tuberculosis. Bloom B.R. Tuberculosis:Pathogenesis, Protection and Control. 1994;85-110 ASM Press, Washington DC.
14. Hobby G.L., Holman A.P., Iseman M.D., Jones J.M. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother. 4:1973;94-104.
15. Jacobs W.R. Jr., Barletta R.G., Udani R., Chan J., Kalkut G., Sosne G., Kieser T., Sarkis G.J., Hatfull G.F., Bloom B.R. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science. 260:1993;819-822.
16. Kent P.T., Kubica G.P. Public Health Mycobacteriology a Guide for the Level III Laboratory. 1985;Centers for Disease Control, Atlanta.
17. Mejia G.I., Castrillon L., Trujillo H., Robledo J.A. Microcolony detection in 7H11 thin layer culture is an alternative for rapid diagnosis of Mycobacterium tuberculosis infection. [see comments] Int J Tuberc Lung Dis. 3:1999;138-142.
18. Pablos-Mendez A., Raviglione M. C., Laszlo A., Binkin N., Rieder H. L., Bustreo F., Cohn D. L., Lambregts-van Weezenbeek C. S., Kim S. J., Chaulet P., & Nunn P. (1998). Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. New Engl J Med 338, 1641-1649.
19. Raviglione M. C., Snider D. E., Jr., & Kochi A. (1995). Global Epidemiology of Tuberculosis: Morbidity and Mortality of a Worldwide Epidemic. JAMA 273, 220-226.
20. Riska P. F., & Jacobs W. R., Jr. (1998). The use of luciferase-reporter phage for antibiotic-susceptibility testing of mycobacteria. Methods Mol Biol 101, 431-455.
21. Riska P. F., Jacobs W. R., Jr., & Alland D. (2000). Molecular determinants of drug resistance in tuberculosis. Int J Tuberc Lung Dis 4, S4-10.
22. Riska P. F., Jacobs W. R., Jr., Bloom B. R., McKitrick J., & Chan J. (1997). Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-α-acetylamino-β-hydroxy propiophenone. J Clin Microbiol 35, 3225-3231.
23. Riska P. F., Su Y., Bardarov S., Freundlich L., Sarkis G., Hatfull G., Carriere C., Kumar V., Chan J., & Jacobs W. R., Jr. (1999). Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J Clin Microbiol 37, 1144-1149.
24. Rusch-Gerdes S., Domehl C., Nardi G., Gismondo M.R., Welscher H.M., Pfyffer G.E. Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J Clin Microbiol. 37:1999;45-48.
25. Siddiqi S. H. (1995). BACTEC TB Product and Procedure Manual, Revision D, D edn. Becton Dickinson, Sparks, MD.
26. Tortoli E., Benedetti M., Fontanelli A., Simonetti M.T. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of mycobacterium tuberculosis to four major antituberculous drugs comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J Clin Microbiol. 40:2002;607-610.
27. Turett G.S., Telzak E.E., Torian L.V., Blum S., Alland D., Weisfuse I., Fazal B.A. Improved Outcomes for Patients with Multidrug-Resistant Tuberculosis. Clin Infect Dis. 21:1995;1238-1244.
28. Wallis R.S., Perkins M.D., Phillips M., Joloba M., Namale A., Johnson J.L., Whalen C.C., Teixeira L., Demchuk B., Dietze R., Mugerwa R.D., Eisenach K., Ellner J.J. Predicting the outcome of therapy for pulmonary tuberculosis. Am J Respir Crit Care Med. 161:2000;1076-1080.